首页> 美国卫生研究院文献>Heliyon >Virulence gene profiles biofilm formation and antimicrobial resistance of Vibrio cholerae non-O1on-O139 bacteria isolated from West Bengal India
【2h】

Virulence gene profiles biofilm formation and antimicrobial resistance of Vibrio cholerae non-O1on-O139 bacteria isolated from West Bengal India

机译:分离自印度西孟加拉邦的霍乱弧菌非O1 /非O139细菌的毒力基因谱生物膜形成和抗药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vibrio cholerae is the causative agent of acute dehydrating diarrhoeal disease cholera. Among 71 V. cholerae non-O1on-O139 isolates, all yielded negative results for ctxA, ctxB and tcpA genes in PCR assay. Few strains were positive for stn (28.38%), and ompU (31.08%) genes. While all isolates were negative for ace gene, only two were positive for zot gene. All strains expressed toxR and toxT genes. It was also found that all isolates were slime-producer and these were capable of forming moderate to high biofilm. Biofilm formation was controlled positively by the transcriptional regulators VpsR and VpsT and was regulated negatively by HapR, as well as CRP regulatory complex. These isolates were resistant to ampicillin, furazolidone, doxycycline, vancomycin, erythromycin, while these were susceptible to ciprofloxacin, gentamycin, kanamycin, polymixin B, norfloxacin, chloramphenicol, sulphamethoxazole-trimethoprim, tetracycline, nalidixic acid, and streptomycin. Indeed, 69.01% isolates were resistant to multiple antibiotics (MAR: resistance to 3 or more antibiotics). Treatment protocols for cholera patients should be based on local antibiogram data.
机译:霍乱弧菌是急性脱水性腹泻病霍乱的病原体。在71株霍乱弧菌的非O1 /非O139分离株中,所有PCR方法中ctxA,ctxB和tcpA基因的检测结果均为阴性。很少有菌株对stn(28.38%)和ompU(31.08%)基因呈阳性。尽管所有分离株的ace基因均为阴性,但只有两个为zot基因阳性。所有菌株均表达toxR和toxT基因。还发现所有分离物都是粘液产生剂,并且能够形成中等至较高的生物膜。生物膜的形成受转录调节因子VpsR和VpsT的正调控,而受HapR和CRP调控复合物的负调控。这些分离株对氨苄青霉素,呋喃唑酮,强力霉素,万古霉素,红霉素有抗性,而对环丙沙星,庆大霉素,卡那霉素,多合霉素B,诺氟沙星,氯霉素,磺胺甲恶唑-三甲氧苄啶,四环素,萘啶霉素,纳西霉素则敏感。实际上,有69.01%的分离株对多种抗生素具有抗药性(MAR:对3种或3种以上抗生素具有抗药性)。霍乱患者的治疗方案应基于当地的抗菌素数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号